OmniAb (OABI) Well-Positioned for Momentum Build-Up in 2026

OmniAb Inc. (NASDAQ:OABI) is one of the 8 Best Life Sciences Penny Stocks to Buy.

On March 5, guidance for 2026 revenues for OmniAb Inc. (NASDAQ:OABI) was estimated at $25 million to $30 million, driven by growth in the partner pipeline and launches of the OmniUltra and xPloration products. According to Matthew Foehr, CEO of OmniAb Inc., 2026 will be characterized by the build-up of momentum with special focus on partnering and programs.

Billion Photos/Shutterstock.com

Foehr also emphasized launching OmniUltra at the Antibody Engineering Conference as the first and only transgenic chicken platform to express ultra-long CDRH3 on a human antibody framework. According to Foehr, OmniUltra would act as a catalyst for growth through partnerships and revenue growth, while xPloration was aimed at bringing single B-cell screening at a high throughput directly to partners’ laboratories, with the potential of adding to the overall growth.

Considering the remarks given by Kurt Gustafson, the Chief Financial Officer, the projected expenses for 2026 would range from $80 million to $85 million as the company becomes more efficient with its operations. Cash operating expenses are expected to range between $50 million and $55 million, whereas the cash balance by the end of the period is projected between $30 million and $35 million.

OmniAb Inc. (NASDAQ:OABI) provides licenses to pharmaceutical and biotech companies for discovery research technology around various parts of the world. To find the best antibodies and other target-binding proteins for partners’ drug development efforts, the company’s technology platform creates and screens diverse antibody repertoires. Animal-based technologies are also offered by the company.

While we acknowledge the risk and potential of OABI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OABI and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.